Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18097001rdf:typepubmed:Citationlld:pubmed
pubmed-article:18097001lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C1413207lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C0017082lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C0054941lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C1306235lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C0152060lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:18097001lifeskim:mentionsumls-concept:C0205154lld:lifeskim
pubmed-article:18097001pubmed:issue1lld:pubmed
pubmed-article:18097001pubmed:dateCreated2007-12-21lld:pubmed
pubmed-article:18097001pubmed:abstractTextCD1 molecules present a variety of microbial glycolipids and self-glycolipids to T cells, but their potential role in humoral responses to glycolipid Ags remains to be established. To address this issue directly, we used GM1/GD1a-deficient mice, which, upon immunization with heat-killed Campylobacter jejuni, develop Guillain-Barré syndrome-associated IgG Abs against the GM1/GD1a sugar chain epitopes of bacterial lipo-oligosaccharides (LOS). Our results showed that anti-ganglioside Abs of the IgG1, IgG2b, and IgG3 isotypes were produced in the absence of group 2 CD1 (CD1d) expression. Unlike mouse and human group 2 CD1 molecules that specifically bound LOS, none of the group 1 CD1 molecules (CD1a, CD1b, and CD1c in humans) were capable of interacting with LOS. Thus, these results indicate CD1-independent pathways for anti-ganglioside Ab production.lld:pubmed
pubmed-article:18097001pubmed:languageenglld:pubmed
pubmed-article:18097001pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18097001pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18097001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18097001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18097001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18097001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18097001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18097001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18097001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18097001pubmed:statusMEDLINElld:pubmed
pubmed-article:18097001pubmed:monthJanlld:pubmed
pubmed-article:18097001pubmed:issn0022-1767lld:pubmed
pubmed-article:18097001pubmed:authorpubmed-author:FurukawaKoich...lld:pubmed
pubmed-article:18097001pubmed:authorpubmed-author:Van KaerLucLlld:pubmed
pubmed-article:18097001pubmed:authorpubmed-author:HirataKoichiKlld:pubmed
pubmed-article:18097001pubmed:authorpubmed-author:SugitaMasahik...lld:pubmed
pubmed-article:18097001pubmed:authorpubmed-author:YukiNobuhiroNlld:pubmed
pubmed-article:18097001pubmed:authorpubmed-author:MatsumotoYuki...lld:pubmed
pubmed-article:18097001pubmed:issnTypePrintlld:pubmed
pubmed-article:18097001pubmed:day1lld:pubmed
pubmed-article:18097001pubmed:volume180lld:pubmed
pubmed-article:18097001pubmed:ownerNLMlld:pubmed
pubmed-article:18097001pubmed:authorsCompleteYlld:pubmed
pubmed-article:18097001pubmed:pagination39-43lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:meshHeadingpubmed-meshheading:18097001...lld:pubmed
pubmed-article:18097001pubmed:year2008lld:pubmed
pubmed-article:18097001pubmed:articleTitleCutting edge: Guillain-Barre syndrome-associated IgG responses to gangliosides are generated independently of CD1 function in mice.lld:pubmed
pubmed-article:18097001pubmed:affiliationDepartment of Neurology and Research Institute for Neuroimmunological Diseases, Dokkyo Medical University School of Medicine, Tochigi, Japan.lld:pubmed
pubmed-article:18097001pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18097001pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:12479entrezgene:pubmedpubmed-article:18097001lld:entrezgene
entrez-gene:14421entrezgene:pubmedpubmed-article:18097001lld:entrezgene
entrez-gene:111334entrezgene:pubmedpubmed-article:18097001lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18097001lld:entrezgene